1. Home
  2. LQDT vs COLL Comparison

LQDT vs COLL Comparison

Compare LQDT & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liquidity Services Inc.

LQDT

Liquidity Services Inc.

HOLD

Current Price

$38.73

Market Cap

1.0B

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$35.57

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDT
COLL
Founded
1999
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
LQDT
COLL
Price
$38.73
$35.57
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$40.00
$51.40
AVG Volume (30 Days)
191.1K
371.1K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
38.10
N/A
EPS
0.46
0.40
Revenue
$476,669,000.00
$780,567,000.00
Revenue This Year
N/A
$8.01
Revenue Next Year
N/A
N/A
P/E Ratio
$81.65
$88.00
Revenue Growth
31.20
23.62
52 Week Low
$21.67
$29.19
52 Week High
$41.28
$50.79

Technical Indicators

Market Signals
Indicator
LQDT
COLL
Relative Strength Index (RSI) 51.86 51.43
Support Level $36.36 $33.91
Resistance Level $38.63 $35.76
Average True Range (ATR) 1.15 1.31
MACD -0.23 -0.13
Stochastic Oscillator 45.12 44.05

Price Performance

Historical Comparison
LQDT
COLL

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Retail Supply Chain Group (RSCG), and Machinio & Software Solutions. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: